Glycomet Trio 1/0.3 Tablet is a specialised combination treatment designed to manage blood sugar levels in adults with type 2 diabetes. It integrates multiple antidiabetic agents to minimise the risk of long-term complications.
Glimepiride stimulates the pancreas to release insulin, metformin reduces glucose production by the liver and improves insulin sensitivity, and voglibose slows the breakdown of carbohydrates in the gut, together giving triple-mechanism blood sugar control.
Take this tablet with the first bite of your main meals, as your doctor prescribes, since voglibose needs to be present with food to work properly.
If your blood sugar drops too low while taking this medicine, treat it with glucose rather than ordinary table sugar, because voglibose can reduce how quickly sucrose raises blood sugar. Tell your doctor about any kidney or liver problems, and mention planned surgery or contrast imaging.








































































